|
Volumn 21, Issue 3, 2006, Pages 823-
|
Notes on angiotensin inhibition and vascular access survival: Time for randomized controlled trials [9]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRADYKININ;
CALCIUM CHANNEL BLOCKING AGENT;
CILAZAPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PENTOXIFYLLINE;
PROSTACYCLIN;
WARFARIN;
CLINICAL TRIAL;
DRUG MECHANISM;
ENDOTHELIUM CELL;
ENZYME INHIBITION;
GRAFT SURVIVAL;
HUMAN;
LETTER;
NONHUMAN;
PRIORITY JOURNAL;
THROMBOCYTE ACTIVATION;
VASCULAR ACCESS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CATHETERS, INDWELLING;
GRAFT OCCLUSION, VASCULAR;
HUMANS;
PROSTHESIS FAILURE;
RANDOMIZED CONTROLLED TRIALS;
RENAL DIALYSIS;
VASCULAR PATENCY;
|
EID: 33644862067
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfi346 Document Type: Letter |
Times cited : (4)
|
References (6)
|